A new automated human leukocyte antigen genotyping strategy to identify DR-DQ risk alleles for celiac disease and type 1 diabetes mellitus

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 12, 2009, Pages 1489-1495

  Lavant, Ewa H ^a,b   Carlson, Joyce A ^b,c  

^a MALMÖ UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Clinical Chemistry in Lund   (Sweden)

Author keywords

Automation; Celiac disease; HLA DR DQgenotyping; PCR SSP (sequence specific priming); Type 1 diabetes mellitus

Indexed keywords

DNA; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; GENOTYPE; HLA TYPING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ALLELES; AUTOMATION; BASE SEQUENCE; CELIAC DISEASE; DIABETES MELLITUS, TYPE 1; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; POLYMERASE CHAIN REACTION;

EID: 73249136337     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.346     Document Type: Article

References (37)

1. Todd JA. Genetic control of autoimmunity in type 1 diabetes. Immunol Today 1990;11:122-129
2. Rewers M, Norris J, Dabelea D. Epidemiology of type 1 diabetes mellitus. Adv Exp Med Biol 2004;552:219-246
3. Jones EY, Fugger L, Strominger JL, Siebold C. MHC class II proteins and disease: a structural perspective. Nat Rev Immunol 2006;6:271-282
4. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and notat-risk groups in the United States: a large multicenter study. Arch Intern Med 2003;163:286-292
5. Dube C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 2005;128(Suppl 1):S57-67.
6. Thorsby E, Lie BA. HLA associated genetic predisposition to autoimmune diseases: genes involved and possible mechanisms. Transpl Immunol 2005;14:175-182
7. Ermann J, Fathman CG. Autoimmune diseases: genes, bugs and failed regulation. Nat Immunol 2001;2:759-761
8. Knip M, Veijola R, Virtanen SM, Hyoty H, Vaarala O, Akerblom HK. Environmental triggers and determinants of type 1 diabetes. Diabetes 2005;54(Suppl 2):S125-36.
9. Kiviniemi M, Hermann R, Nurmi J, Ziegler AG, Knip M, Simell O, et al. A high-throughput population screening system for the estimation of genetic risk for type 1 diabetes: an application for the TEDDY (The Environmental Determinants of Diabetes in the Young) study. Diabetes Technol Ther 2007;9:460-472
10. Wolters VM, Wijmenga C. Genetic background of celiac disease and its clinical implications. Am J Gastroenterol 2008;103:190-195
11. Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 2003;61:105-117
12. Margaritte-Jeannin P, Babron MC, Bourgey M, Louka AS, Clot F, Percopo S, et al. HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease. Tissue Antigens 2004;63:562-567
13. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 1989;169:345-350
14. Karell K, Louka AS, Moodie SJ, Ascher H, Clot F, Greco L, et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 2003;64:469-477
15. Vader W, Stepniak D, Kooy Y, Mearin L, Thompson A, van Rood JJ, et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci USA 2003;100:12390-12395
16. Bourgey M, Calcagno G, Tinto N, Gennarelli D, Margaritte-Jeannin P, Greco L, et al. HLA related genetic risk for coeliac disease. Gut 2007;56:1054-1059
17. Ploski R, Ek J, Thorsby E, Sollid LM. On the HLA-DQ (alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens 1993;41:173-177
18. Megiorni F, Mora B, Bonamico M, Barbato M, Nenna R, Maiella G, et al. HLA-DQ and risk gradient for celiac disease. Hum Immunol 2009;70:55-59
19. Megiorni F, Mora B, Bonamico M, Nenna R, Di Pierro M, Catassi C, et al. A rapid and sensitive method to detect specific human lymphocyte antigen (HLA) class II alleles associated with celiac disease. Clin Chem Lab Med 2008; 46:193-196
20. Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulindependent diabetes mellitus. Nature 1987;329:599-604.
21. Pociot F, McDermott MF. Genetics of type 1 diabetes mellitus. Genes Immun 2002;3:235-249
22. Ilonen J, Sjoroos M, Knip M, Veijola R, Simell O, Akerblom HK, et al. Estimation of genetic risk for type 1 diabetes. Am J Med Genet 2002;115:30-36
23. Undlien DE, Lie BA, Thorsby E. HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved? Trends Genet 2001;17:93-100.
24. Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008;57: 1084-1092
25. Sheehy MJ, Scharf SJ, Rowe JR, Neme de Gimenez MH, Meske LM, Erlich HA, et al. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest 1989;83:830-835
26. She JX. Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immunol Today 1996;17:323-329
27. Lambert AP, Gillespie KM, Thomson G, Cordell HJ, Todd JA, Gale EA, et al. Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab 2004;89:4037-4043
28. Thomson G, Valdes AM, Noble JA, Kockum I, Grote MN, Najman J, et al. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens 2007;70:110-127
29. Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. Br Med J 328:750-754
30. Rich SS, Concannon P, Erlich H, Julier C, Morahan G, Nerup J, et al. The Type 1 Diabetes Genetics Consortium. Ann NY Acad Sci 2006;1079:1-8.
31. ®. Available at: http://www.ebi.ac.uk/imgt/hla/, Accessed July 2008.
32. Bergstrom TF, Josefsson A, Erlich HA, Gyllensten U. Recent origin of HLA-DRB1 alleles and implications for human evolution. Nat Genet 1998;18:237-242
33. Kotsch K, Wehling J, Blasczyk R. Sequencing of HLA class II genes based on the conserved diversity of the non-coding regions: sequencing based typing of HLADRB genes. Tissue Antigens 1999;53:486-497
34. Eising S, Svensson J, Skogstrand K, Nilsson A, Lynch K, Andersen PS, et al. Type 1 diabetes risk analysis on dried blood spot samples from population-based newborns: design and feasibility of an unselected case-control study. Paediatr Perinat Epidemiol 2007;21:507-517
35. Emery LM, Babu S, Bugawan TL, Norris JM, Erlich HA, Eisenbarth GS, et al. Newborn HLA-DR, DQ genotype screening: age-and ethnicity-specific type 1 diabetes risk estimates. Pediatr Diabetes 2005;6:136-144
36. Seissler J, Hatziagelaki E, Scherbaum WA. Modern concepts for the prediction of type 1 diabetes. Exp Clin Endocrinol Diabetes 2001;109(Suppl 2):S304-16.
37. The Type 1 Diabetes Genetics Consortium is a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Human Genome Research Institute (NHGRI), National Institute of Child Health and Human Development (NICHD), and Juvenile Diabetes Research Foundation International (JDRF) and supported by U01 DK062418.